Largest Longevity-Focused Companies by Market Capitalization

Over 300 publicly traded companies now work on therapies and technologies aimed at extending healthy human lifespan — a field that sits at the intersection of biotech, life sciences, and healthcare. Most longevity-focused stocks list on NASDAQ, with a smaller number trading on the NYSE and Euronext Growth Paris.

The sector draws an important distinction between lifespan — total years alive — and healthspan, the number of those years spent in good health. Humans typically spend their final decade in declining health, which is the gap these companies aim to close. Research areas span telomere biology, senescent cell clearance (senolytics), AI-driven aging analytics, regenerative cell therapy, and age-related muscle and neurological conditions.

Notable publicly traded longevity companies include:

• Geron Corporation (NASDAQ: GRON) — a telomerase-focused biopharma company, public since 1996, developing therapies built on Nobel Prize–recognized discoveries about telomeres and cellular aging.
• BioAge Labs (NASDAQ: BIOA) — founded in 2015, uses a proprietary human longevity data platform and AI to link molecular signatures to healthy aging trajectories.
• Unity Biotechnology (NASDAQ: UBX) — formed in 2009, develops drugs that remove senescent cells, with early backing from Peter Thiel and Jeff Bezos.
• Longeveron Inc. (NASDAQ: LGVN) — a Miami-based clinical-stage company developing allogeneic cell therapies for aging-related conditions.
• Telomir Pharmaceuticals (NASDAQ) — a preclinical-stage company founded in 2021, focused on age-reversal therapeutics rooted in telomere biology.
• Biophytis (Euronext Growth Paris: ALBPS) — a French biotech founded in 2006, developing treatments for sarcopenia and age-related muscle degeneration.

Several of the best-funded longevity organizations — such as Alphabet’s Calico Life Sciences (founded in 2013) and Altos Labs — remain private, meaning the publicly traded universe skews toward clinical-stage pure-plays alongside larger pharmaceutical companies with aging-related programs. Companies working on CRISPR and gene editing also share some overlap with longevity research.

Regulated broker Invest now: Buy Stocks & ETFs in just 15 minutes from $50 Your capital is at risk. Free demo account & education

The table below ranks the leading publicly traded longevity-focused companies by market capitalization, with live pricing data updated throughout the trading day.